Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Survey Finds Competitive Bidding Restricts Access To Diabetes Products

This article was originally published in The Gray Sheet

Executive Summary

The American Association of Diabetes Educators surveyed suppliers participating in the nationwide competitive bidding system for mail-ordered diabetes testing systems and found that they are not offering access to as many brands as they initially promised in their bids.

You may also be interested in...

FDA Distinguishes Pre-Market Expectations For Professional Vs. Home Glucose Meters

The agency for the first time issued distinct guidance documents for blood glucose meters used in professional settings and those issued over-the-counter for self-monitoring tests by lay-persons. FDA is collecting comments on draft versions of the guidelines.

Insulin Pumps, Including Sensor-Augmented, Enter Competitive Bidding

Now that insulin pumps are part of CMS’ competitive bidding program, there is a possibility of reimbursement reductions down the road. And in a separate process, CMS denied Medtronic’s request to establish a new HCPCS code for sensor-augmented insulin pumps.

Blood Glucose Meter Accuracy Problems Acknowledged By FDA, Industry And Clinicians

Certain 510(k)-cleared blood glucose meters do not perform at the regulatory standards for which they were cleared after they hit the market, stakeholders agree. FDA is working on the matter, but no clear plan of action was laid out at a Diabetes Technology Society meeting last week.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts